Morgan Stanley raised the firm’s price target on Lazard (LAZ) to $61 from $47 and keeps an Underweight rating on the shares. With the M&A cycle “gaining steam,” the firm estimates M&A volumes to fully revert back to three decade averages versus nominal GDP in 2027 and is rolling its valuation year from 2026 to 2027, the analyst tells investors in a note on the Midcap Advisors group.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LAZ:
- Lazard Announces Leadership Change in Asset Management
- Lazard Appoints Dmitry Shevelenko to Board of Directors
- Keefe Bruyette upgrades Lazard on improving flow narrative
- Lazard upgraded to Outperform from Market Perform at Keefe Bruyette
- Coca-Cola (KO) Eyes Costa Coffee Sale despite Billions in Potential Losses
